Biogened S.A.

WSE-BGD
Warsaw Stock Exchange NYSE
Pharmaceutical Preparations
Global Rank
#36807
Country Rank
#288
Market Cap
17.47 M
Price
7.11
Change (%)
11.26%
Volume
53

Biogened S.A.'s latest marketcap:

17.47 M

As of 06/07/2025, Biogened S.A.'s market capitalization has reached $17.47 M. According to our data, Biogened S.A. is the 36807th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 17.47 M
Revenue (ttm) 30.3 M
Net Income (ttm) 1.27 M
Shares Out 2.46 M
EPS (ttm) 0.52
Forward PE 0.00
Ex-Dividend Date 09/11/2025
Earnings Date 05/12/2025
Market Cap Chart
Data Updated: 06/07/2025

Biogened S.A.'s yearly market capitalization.

Biogened S.A. has seen its market value grow from zł20.88 M to zł65.83 M since 2020, representing a total increase of 215.29% and an annual compound growth rate (CAGR) of 29.53%.
Date Market Cap Change (%)
06/07/2025 zł65.83 M 16.52%
12/30/2024 zł56.5 M 27.78%
12/29/2023 zł44.21 M 41.73%
12/29/2022 zł31.2 M 47.67%
12/30/2021 zł21.12 M 1.18%
12/30/2020 zł20.88 M

Company Profile

About Biogened S.A.

Biogened S.A. is a pharmaceutical company specializing in the development, production, and distribution of healthcare products in Poland.

Product Portfolio

  • Dermo-Cosmetics: Marketed under the Dermedic brand, offering specialized skincare solutions.
  • Thermal Water: A premium product catering to dermatological and cosmetic needs.

Global Reach

In addition to serving the domestic market, Biogened S.A. exports its products internationally.

Company Background

Founded in 2007, the company is headquartered in Lódz, Poland.

Frequently Asked Questions

  • What is Biogened S.A.'s (WSE-BGD) current market cap?
    As of 06/07/2025, Biogened S.A. (including the parent company, if applicable) has an estimated market capitalization of $17.47 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
  • Biogened S.A. global market capitalization ranking is approximately 36807 as of 06/07/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

MarketCapWatch.com ranks all listed companies worldwide, providing unique insights into market capitalization across industries. As one of the most comprehensive ranking platforms, it covers companies of all sizes and sectors.

Ranking
Community

Copyright © 2025. All rights reserved

Important Disclaimer: All content provided on this website, including hyperlinked pages, related applications, forums, blogs, social media accounts, and other platforms ("the Site"), is for general informational purposes only and sourced from third-party providers. We make no guarantees regarding the accuracy, completeness, or timeliness of the content.

None of the information presented constitutes financial, legal, or professional advice. Users should conduct their own research, evaluation, and verification before making any decisions. Investing and trading carry significant risks that may lead to substantial losses. Therefore, we strongly recommend consulting a qualified financial advisor before taking any action.